Name: Kalaris Therapeutics, Inc. (KLRS) Balance Sheet
Creator: FinSpry

Kalaris Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Kalaris Therapeutics, Inc. (KLRS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	1.64	3.17	233.80	248.12	356.32
Cash & Short-Term Investments	1.64	3.17	233.80	248.12	356.32
Accounts Receivable	0.00	0.21	0.16	0.05	0.45
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.97	0.16	2.00	1.10	0.00
Total Current Assets	2.61	3.33	243.05	253.35	361.32
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	2.19	32.56	31.29	9.50
Other Non-Current Assets	0.41	0.97	3.46	1.95	0.00
Total Non-Current Assets	0.00	3.16	36.03	33.25	9.50
Total Assets	6.16	3.33	277.08	286.59	370.82
Current Liabilities
Accounts Payable	1.56	2.36	17.12	31.26	9.07
Accrued Liabilities	2.13	1.00	2.52	0.00	0.00
Other Current Liabilities	1.11	0.58	0.42	1.74	0.57
Total Current Liabilities	24.70	3.94	24.34	37.85	12.29
Non-Current Liabilities
Long-Term Debt	0.00	16.65	28.22	23.48	5.46
Other Non-Current Liabilities	32.08	0.00	0.26	0.00	0.00
Total Non-Current Liabilities	0.00	16.65	28.22	23.48	5.46
Total Liabilities	56.78	3.94	52.56	61.33	17.76
Stockholders' Equity
Retained Earnings	-116.56	-47.39	-466.24	-297.22	-125.22
Accumulated Other Comprehensive Income	0.00	0.00	0.00	-0.16	-0.11
Additional Paid-in Capital	0.00	802.04	690.75	522.48	478.27
Shares Outstanding	0.00	18.70	18.70	0.00	0.00
Total Stockholders' Equity	-50.62	-0.61	224.52	225.27	353.06
Total Liabilities & Equity	118.55	190.80	277.08	286.59	370.82